Skip to main content
Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc. — Investor Relations & Filings

Ticker · ARCT ISIN · US03969T1097 US Manufacturing
Filings indexed 379 across all filing types
Latest filing 2026-03-26 Major Shareholding Noti…
Country US United States of America
Listing US ARCT

About Arcturus Therapeutics Holdings Inc.

https://arcturusrx.com/

Arcturus Therapeutics Holdings Inc. is a commercial-stage messenger RNA (mRNA) medicines company focused on the discovery, development, and commercialization of therapeutics and vaccines. The company's primary areas of interest are infectious diseases and rare diseases, with a particular emphasis on respiratory and liver conditions. Its development pipeline includes candidates for Ornithine Transcarbamylase (OTC) deficiency (ARCT-810) and Cystic Fibrosis (ARCT-032), as well as vaccine programs. Arcturus leverages its proprietary technologies, including the LUNAR® lipid-mediated nanoparticle delivery system and the STARR® self-amplifying mRNA platform, to advance its portfolio of RNA-based medicines.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G/A - Arcturus Therapeutics Holdings Inc. (0001768224) (Subject)
Major Shareholding Notification
2026-03-26 English
10-K - ARCTURUS THERAPEUTICS HOLDINGS INC. (0001768224) (Filer)
Annual Report FY 2025
2026-03-03 English
8-K - ARCTURUS THERAPEUTICS HOLDINGS INC. (0001768224) (Filer)
Regulatory Filings
2026-03-03 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-03 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-01-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.